Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma-Reference-Cited by-同舟云学术

Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma

Published:2018-06-12 Issue:3 Volume:68 Page:949-963
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Nepal Chirag¹,O'Rourke Colm J.¹,Oliveira Douglas V.N.P.¹,Taranta Andrzej¹,Shema Steven²,Gautam Prson³,Calderaro Julien⁴⁵⁶^ORCID,Barbour Andrew⁷,Raggi Chiara⁸,Wennerberg Krister¹³,Wang Xin W.⁹,Lautem Anja¹⁰,Roberts Lewis R.¹¹^ORCID,Andersen Jesper B.¹^ORCID

Affiliation:

1. Biotech Research and Innovation Centre, Department of Health and Medical Sciences; University of Copenhagen; Copenhagen Denmark

2. Center for Cancer Research Genomics Core, National Cancer Institute; National Institutes of Health; Bethesda MD

3. Institute for Molecular Medicine Finland; University of Helsinki; Helsinki Finland

4. Assistance Publique-Hôpitaux de Paris, Department of Pathology; CHU Henri Mondor; Créteil France

5. Faculté de Médecine; Université Paris-Est Créteil; Créteil France

6. Inserm U955 Equipe 18; Institut Mondor de Recherche Biomédicale; Créteil France

7. University of Queensland; Brisbane Australia

8. Center for Autoimmune Liver Diseases; IRCCS Istituto Clinico Humanitas; Rozzano (MI) Italy

9. Laboratory of Human Carcinogenesis, Center for Cancer Research; National Cancer Institute; Bethesda MD

10. Department of General, Visceral and Transplantation Surgery; University Medical Center Mainz; Mainz Germany

11. Division of Gastroenterology and Hepatology; Mayo Clinic College of Medicine; Rochester MN

Funder

Sundhed og Sygdom, Det Frie Forskningsråd

Kraeftens Bekaempelse

Novo Nordisk Foundation

A.P. Møller Foundation

H2020 European Commission Marie Sklodowska-Curie Action

Lundbeckfonden

Intramural Research Program of the Center for Cancer Research

National Cancer Institute

National Institutes of Health

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29764/fullpdf

Reference45 articles.

1. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA);Banales;Nat Rev Gastroenterol Hepatol,2016

2. Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics Database;Yao;BMC Gastroenterol,2016

3. Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting;Sirica;Hepatology,2014

4. Cholangiocarcinoma;Razumilava;Lancet,2014

5. High lifetime risk of cancer in primary sclerosing cholangitis;Claessen;J Hepatol,2009

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted therapies in biliary tract cancer—when precision becomes imprecise;ESMO Gastrointestinal Oncology;2024-09

2. Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver (AFEF);Liver International;2024-07-05

3. Differential isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 mutation-related landscape in intrahepatic cholangiocarcinoma;The Oncologist;2024-06-06

4. Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in Cholangiocarcinoma;Gastroenterology;2023-12

5. Role of immunophenotypic characterisation in prognostic subtyping of intrahepatic cholangiocarcinoma;Pathology;2023-12